Alpha Tau Medical (NASDAQ: DRTS) is set to report earnings on November 19, 2026, with estimated earnings of -$0.15 per share and revenue of $125,000. Positive clinical results from the U.S. REGAIN tr...
Williams-Sonoma, Inc. (NYSE: WSM) is set to r...
TD Cowen reiterated its Buy rating on Gilead ...
ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) reported Q3 2026 earnings of $6.88 per share, significantly exceeding the $5.12 estimate. Revenue for Q3 2026 reached $2.71 billion, surpassi
Freedom Broker downgraded VolitionRx to Hold. VolitionRx reports significant progress with its Nu.Q diagnostic platform, including peer-reviewed validation in sepsis and early-stage cancer detection
Lowe's (NYSE: LOW) reported adjusted earnings per share of $3.10, beating estimates of $2.88. Revenue reached $22.80 billion, surpassing the $22.40 billion estimate, with comparable sales up 1.8%. Th
Oppenheimer reiterated its Outperform rating on Microsoft (NASDAQ: MSFT) when shares were at $506.24. Microsoft presented Copilot as a lower-cost option than OpenAI’s ChatGPT and Anthropic’s Clau
Target Corporation (NYSE: TGT) surpassed analyst estimates for both earnings per share and revenue. The retailer achieved its strongest quarterly sales growth in approximately five years, driven
Raymond James upgraded Charles Schwab to Strong Buy. Client assets reached $13.27 trillion in October 2026, up 12% year over year, with core net new assets rising 50% to $66.5 billion. Schwab opened